Skip to main content
SpringerLink
Log in

Trimetazidine protects isolated rat hearts against ischemia–reperfusion injury in an experimental timing – dependent manner

  • ORIGINAL CONTRIBUTION
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Abstract

The present study investigated the tolerance of the isolated rat heart to ischemia–reperfusion after administration of trimetazidine (TMZ) at different experimental phases, as well as the possible involvement of p38 MAPK and JNKs in this response. Isolated rat hearts were perfused in Langendorff mode. Untreated hearts after stabilization (S) were subjected to 20 min of zero-flow global ischemia (I) and 45 min of reperfusion (R), (NORM), n = 9. TMZ (10–5 M) was administered (in the perfusate): a) only at S phase, (TMZ–STAB), n = 8, b) only at R, (TMZ–REP), n = 8 and c) during both S and R, (TMZ–STAB+REP), n = 8. Recovery of left ventricular developed pressure at 45 min of R (Rec) was significantly higher in TMZ–STAB and TMZ–STAB+REP and LDH release was lower in TMZ–STAB+REP and TMZ–STAB than NORM, [1153.2 (121.0) and 1152.1 (86.8) vs 1573.5 (138.2), P < 0.05]. TMZ induced cardioprotection did not involve p38 MAPK and JNKs. Phospho–p38 MAPK and JNKs levels after I/R were not changed with TMZ treatment. In TMZ–REP, Rec and LDH release were similar to NORM, but the rate of functional recovery (ratio of Rec at 10 min of R to Rec) was 86.7% (13.3) for TMZ–REP vs 53.8% (7.7) for NORM, P < 0.05. This effect was associated with decreased myocardial lactate content early at reperfusion. In conclusion, preischemic administration of TMZ protects against I/R injury while TMZ given only at reperfusion accelerates recovery of function without reducing the extent of injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Allibardi S, Chierchia SL, Margonato V, Merati G, Neri G, Dell’Antonio G, Samaja M (1998) Effects of trimetazidine on metabolic and functional recovery of postischaemic rat hearts. Cardiovasc Drugs Ther 12:543–549

    Google Scholar 

  2. Armstrong SC (2004) Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 61:427–436

    Google Scholar 

  3. Bogoyevitch M, Gillespie-Brown J, Ketterman A, Fuller SJ, Ben-Levy R, Ashworth A, Marshall CJ, Sugden PH (1996) Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart: p38/RK mitogen-activated protein kinases and c-jun N-Terminal kinases are activated by ischaemia/reperfusion. Circ Res 79:162–173

    CAS  PubMed  Google Scholar 

  4. Boucher FR, Hearse DJ, Opie LH (1994) Effects of trimetazidine on ischaemic contracture in isolated perfused rat heart. J Cardiovasc Pharmacol 24:45–49

    Google Scholar 

  5. Cokkinos DV (2001) Can metabolic manipulation reverse myocardial dysfunction? Eur Heart J 22:2138–2139

    Google Scholar 

  6. El Banani H, Bernard M, Baetz D, Cabanes E, Cozzone P, Lucien A, Feuvray D (2000) Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine; comparison between low-and zero flow ischaemia. Cardiovasc Res 47:688–696

    Google Scholar 

  7. Hausenloy DJ, Yellon DM (2004) New directions for protecting the heart against ischemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 61:448–460

    Google Scholar 

  8. Griffin JL, White LT, Lewandowski ED (2000) Substrate-dependent proton load and recovery of stunned hearts during pyruvate dehydrogenase stimulation. Am J Physiol Heart Circ Physiol 279 (1):H361–H367

    Google Scholar 

  9. Kantor PF, Lucien A, Kozak R, Lopaschuk GD (2000) The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long chain 3-ketoacyl coenzyme A thiolase. Circ Res 86:580–588

    Google Scholar 

  10. Knight RJ, Buxton DB (1996) Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischaemia and reperfusion in the perfused rat heart. Biochem Biophys Res Commun 218:83–88

    Google Scholar 

  11. Kudej RK, White LT, Kudej AB, Vatner SF, Lewandowski ED (2002) Brief increase in carbohydrate oxidation after reperfusion reverses myocardial stunning in conscious pigs. Circulation 106:2836–2841

    Google Scholar 

  12. Lavanchy N, Martin J, Rossi A (1987) Antischaemic effects of trimetazidine: 31P–NMR spectroscopy in the isolated rat heart. Arch Int Pharmacodyn Ther 286:97–110

    Google Scholar 

  13. Liu B, Clanachan AS, Schulz R, Lopaschuk GD (1996) Cardiac ef.ciency is improved after ischaemia by altering both the source and fate of protons. Circ Res 79:940–948

    Google Scholar 

  14. Lopaschuk GD (1998) Treating ischaemic heart disease by pharmacologically improving cardiac energy metabolism. Am J Cardiol 82:14K–17K

    Google Scholar 

  15. Mackay K, Mochly-Rosen D (1999) An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischaemia. J Biol Chem 274 (10):6272–6279

    Article  CAS  PubMed  Google Scholar 

  16. Marais E, Genade S, Huisamen B, Strijdom JG, Moolman JA, Lochner A (2001) Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion. J Mol Cell Cardiol 33:769–778

    CAS  PubMed  Google Scholar 

  17. Marzilli M (2003) Cardioprotective effects of trimetazidine: a review. Curr Med Res Opin 19 (7):661–672

    Google Scholar 

  18. Maupoil V, Rochette L, Tabard A, Clauser P, Harpey C (1990) Direct measurement of free radical generation in isolated rat heart by electron paramagnetic resonance spectroscopy: effect of trimetazidine. Adv Exp Med Biol 264:377–382

    Google Scholar 

  19. McVeigh JJ, Lopaschuk GD (1990) Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol 259:H1079–H1085

    Google Scholar 

  20. Minners J, van der Boss EJ, Yellon DM, Schwalb H, Opie LH, Sack MN (2000) Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc Res 47:68–73

    Google Scholar 

  21. Opie LH (2003) Preconditioning and metabolic anti-ischaemic agents. Eur Heart J 24:1854–1856

    Google Scholar 

  22. Pantos C, Malliopoulou V, Mourouzis I, Karamanoli E, Paizis I, Steimberg N, Varonos D, Cokkinos DV (2002) Longterm thyroxine administration protects the heart in a similar pattern as ischaemic preconditioning. Thyroid 12:325–329

    Google Scholar 

  23. Pantos C, Malliopoulou V, Mourouzis I, Sfakianoudis K, Tzeis S, Doumba P, Xinaris Ch, Cokkinos AD, Carageorgiou H, Varonos D, Cokkinos DV (2003a) Propylthiouracil induced hypothyroidism is associated with increased tolerance of the isolated rat heart to ischaemia-reperfusion. J Endocrinol 178 (3):427–435

    Google Scholar 

  24. Pantos C, Malliopoulou V, Paizis I, Moraitis P, Mourouzis I, Tzeis S, Karamanoli E, Cokkinos DD, Carageorgiou H, Varonos D, Cokkinos DV (2003b) Thyroid hormone and cardioprotection; study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart. Mol Cell Biochem 242:173–180

    Google Scholar 

  25. Pantos C, Malliopoulou V, Mourouzis I, Moraitis P, Tzeis S, Thempeyioti A, Paizis I, Cokkinos AD, Carageorgiou H, Varonos D, Cokkinos DV (2003c) Involvement of p38 MAPK and JNK in the heat stress induced cardioprotection. Bas Res Cardiol 98:158–164

    Google Scholar 

  26. Pantos C, Malliopoulou V, Varonos D, Cokkinos DV (2004) Thyroid hormone and phenotypes of cardioprotection Basic Res Cardiol 99:101–120

    Google Scholar 

  27. Racey-Burns LA, Burns AH, Summer WR, Shepherd RE (1989) The effects of dichloroacetate on the isolated no flow arrested rat heart. Life Sci 44 (26):2015–2023

    Google Scholar 

  28. Renaud JF (1988) Internal pH, Na+ and Ca2+ regulation by trimetazidine during cardiac cell acidosis. Cardiovasc Drugs Ther 1:677–686

    Google Scholar 

  29. Stanley WC, Marzilli M (2003) Metabolic therapy in the treatment of ischaemic heart disease: the pharmacotherapy of trimetazidine. Fundamental Clinical Pharmacol 17:133–145

    Google Scholar 

  30. Taegtmeyer H, King LM, Jones BE (1998) Energy substrate metabolism, myocardial ischaemia, and targets for pharmacotherapy. Am J Cardiol 82:54K–60K

    Google Scholar 

  31. White LT, O’Donnell JM, Griffin J, Lewandowski ED (1999) Cytosolic redox state mediates postischaemic response to pyruvate dehydrogenase stimulation. Am J Physiol 277:H626–H634

    Google Scholar 

  32. Yellon DM, Downey JM (2003) Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83:1113–1151

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of Athens, 75 Mikras Asias Ave., 11527 Goudi, Athens, Greece

    C. Pantos, S. Tzeis, I. Paizis, I. Mourouzis, P. Moraitis, V. Malliopoulou, E. D. Politi, H. Karageorgiou & D. Varonos

  2. 1st Cardiology Department, Onassis Cardiac Surgery Center, 356 Sygrou Ave., 17674 Kallithea, Athens, Greece

    D. V. Cokkinos

  3. Institut de Recherches Internationales Servier, 6 place des Pleiades, 92415, Courbevoie Cedex, France

    A. Bescond-Jacquet

Authors
  1. C. Pantos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Bescond-Jacquet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Tzeis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Paizis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. Mourouzis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Moraitis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. V. Malliopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. D. Politi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H. Karageorgiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. D. Varonos
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. D. V. Cokkinos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Pantos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pantos, C., Bescond-Jacquet, A., Tzeis, S. et al. Trimetazidine protects isolated rat hearts against ischemia–reperfusion injury in an experimental timing – dependent manner. Basic Res Cardiol 100, 154–160 (2005). https://doi.org/10.1007/s00395-004-0505-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00395-004-0505-4

Key words

Search

Navigation